Advancing pediatric psychiatry research: Linking neurobiological processes to novel treatment and diagnosis through the Research Domain Criteria (RDoC) project

Therapeutic Innovation and Regulatory Science

Volumn 49, Issue 5, 2015, Pages 643-646

  Drury, Stacy ^a   Cuthbert, Bruce ^b  

^a TULANE UNIVERSITY   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Clinical treatment; Genetics; Neuroscience; RDoC

Indexed keywords

BEHAVIORAL SCIENCE; CHILD PSYCHIATRY; CHILDHOOD DISEASE; CLINICAL RESEARCH; CYSTIC FIBROSIS; DRUG INDUSTRY; GENETICS; MEDICAL LITERATURE; MEDICAL RESEARCH; MENTAL DISEASE; MENTAL HEALTH; MOLECULAR GENETICS; NEUROBIOLOGY; PATIENT CARE; PEDIATRICS; PRIORITY JOURNAL; REVIEW;

EID: 84960084391     PISSN: 21684790     EISSN: 21684804     Source Type: Journal    
DOI: 10.1177/2168479015596019     Document Type: Review

References (18)

1. Kessler R, Chiu W, Demler O, Merikangas K, Walters E. Preva- lence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62:617-627.
2. Greater London Authority. London mental health: the invisible costs of mental ill health. January 2014. https://www.london.gov.uk/sites/default/files/Mental%20health%20report.pdf. Accessed April 2015.
3. Health Care Cost Institute Inc. Children’s health care spending report: 2007-2010. http://www.healthcostinstitute.org/files/HCCI_CHCSR20072010.pdf. 2012. Accessed April 2015.
4. Gillman M. Developmental origins of health and disease. New Engl J Med. 2005;353:1848.
5. Goldstein B, Schaffer A, Wang S, Blanco C. Excessive and premature new-onset cardiovascular disease among adults with bipolar disorder in the US NESARC cohort. J Clin Psychiatry. 2015;76:163-169.
6. Sin NL, Yaffe K, Whooley MA. Depressive symptoms, cardiovascular disease severity, and functional status in older adults with coronary heart disease: the heart and soul study. J Am Geriatr Soc. 2015;63:8-15.
7. Felitti M, Vincent J, Anda M, et al. Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults: the Adverse Childhood Experiences (ACE) Study. Am J Prev Med. 1998;14:245-258.
8. Shonkoff JP. Building a new biodevelopmental framework to guide the future of early childhood policy. Child Dev. 2010;81: 357-367.
9. Shonkoff JP, Garner AS, CHILD TCOPAO, et al. The lifelong effects of early childhood adversity and toxic stress. Pediatrics. 2012;129:e232-e246.
10. Riordan JR, Rommens JM, Kerem B, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science. 1989;245:1066-1073.
11. Caspi A, Sugden K, Moffitt T, et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science. 2003;301:386-389.
12. Accurso F, Rowe S, Clancy J, et al. Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation. N Engl J Med. 2010;363:1991-2003.
13. Cutting G. Cystic fibrosis genetics: from molecular understanding to clinical application. Nat Rev Genet. 2015;16:45-56.
14. Ravindranath Y. Recent advances in pediatric acute lymphoblastic and myeloid leukemia. Curr Opin Oncol. 2003;15:23-35.
15. Ross M, Zhou X, Song G, et al. Classification of pediatric acute lymphoblastic leukemia by gene expression profiling. Blood. 2003;102:2951-2959.
16. Matsumoto Y, Fabbri C, Pellegrini S, et al. Serotonin transporter gene: a new polymorphism may affect response to antidepressant treatments in major depressive disorder. Mol Diagn Ther. 2014; 18:567-577.
17. El-Hage W, Vourc’h P, Gaillard P, et al. The BDNF Val66Met polymorphism is associated with escitalopram response in depressed patients. Psychopharmacology. 2015;232:575-581.
18. Eley TS, Hudson JL, Creswell C, et al. Therapygenetics: the 5HTTLPR and response to psychological therapy. Mol Psychiatry. 2012;17:236-237.